1. Home
  2. GLMD vs JXG Comparison

GLMD vs JXG Comparison

Compare GLMD & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLMD
  • JXG
  • Stock Information
  • Founded
  • GLMD 2000
  • JXG N/A
  • Country
  • GLMD Israel
  • JXG China
  • Employees
  • GLMD N/A
  • JXG N/A
  • Industry
  • GLMD Biotechnology: Pharmaceutical Preparations
  • JXG
  • Sector
  • GLMD Health Care
  • JXG
  • Exchange
  • GLMD Nasdaq
  • JXG Nasdaq
  • Market Cap
  • GLMD 4.5M
  • JXG 5.2M
  • IPO Year
  • GLMD 2014
  • JXG N/A
  • Fundamental
  • Price
  • GLMD $2.70
  • JXG $2.39
  • Analyst Decision
  • GLMD
  • JXG
  • Analyst Count
  • GLMD 0
  • JXG 0
  • Target Price
  • GLMD N/A
  • JXG N/A
  • AVG Volume (30 Days)
  • GLMD 21.6K
  • JXG 34.7K
  • Earning Date
  • GLMD 04-03-2025
  • JXG 12-06-2024
  • Dividend Yield
  • GLMD N/A
  • JXG N/A
  • EPS Growth
  • GLMD N/A
  • JXG N/A
  • EPS
  • GLMD N/A
  • JXG 2.20
  • Revenue
  • GLMD N/A
  • JXG $38,490,872.00
  • Revenue This Year
  • GLMD N/A
  • JXG N/A
  • Revenue Next Year
  • GLMD N/A
  • JXG N/A
  • P/E Ratio
  • GLMD N/A
  • JXG $1.09
  • Revenue Growth
  • GLMD N/A
  • JXG N/A
  • 52 Week Low
  • GLMD $2.24
  • JXG $0.75
  • 52 Week High
  • GLMD $23.80
  • JXG $4.92
  • Technical
  • Relative Strength Index (RSI)
  • GLMD 49.41
  • JXG N/A
  • Support Level
  • GLMD $2.24
  • JXG N/A
  • Resistance Level
  • GLMD $2.72
  • JXG N/A
  • Average True Range (ATR)
  • GLMD 0.20
  • JXG 0.00
  • MACD
  • GLMD 0.02
  • JXG 0.00
  • Stochastic Oscillator
  • GLMD 71.47
  • JXG 0.00

About GLMD Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.

About JXG JX Luxventure Limited Common Stock

JX Luxventure Group Inc, formerly JX Luxventure Ltd is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Airline tickets and tourism services, Software Solutions for Tourism Cross-border operation, and Tourism Cross-border Merchandise. The majority of the group revenue is generated from Tourism products.

Share on Social Networks: